clinical trials

Can social communities transform clinical trials?

Big pharma is one of the main scapegoats for the steeply rising costs of medical care. This might make sense when you learn how staggering the pricetag on necessary processes—like clinical trials—can be.

According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. pharmaceutical industry’s advocacy group, it costs $1.3B (in 2005 dollars) to bring a new drug to market. » Read more